Effects of obesity, diabetes and exercise on Fndc5 gene expression and irisin release in human skeletal muscle and adipose tissue: In vivo and in vitro studies

Journal of Physiology

Volumn 592, Issue 5, 2014, Pages 1091-1107

  Kurdiova, Timea ^a   Balaz, Miroslav ^a   Vician, Marek ^b   Maderova, Denisa ^a   Vlcek, Miroslav ^a   Valkovic, Ladislav ^h,i   Srbecky, Miroslav ^d   Imrich, Richard ^a   Kyselovicova, Olga ^c   Belan, Vitazoslav ^d   Jelok, Ivan ^f   Wolfrum, Christian ^g   Klimes, Iwar ^a   Krssak, Martin ^i,j   Zemkova, Erika ^c   Gasperikova, Daniela ^a   Ukropec, Jozef ^a   Ukropcova, Barbara ^a,e  

^a INSTITUTE OF EXPERIMENTAL ENDOCRINOLOGY   (Slovakia)

^b SLOVAK MEDICAL UNIVERSITY   (Slovakia)

^c Faculty of Education   (Slovakia)

^d UNIVERSITY HOSPITAL BRATISLAVA   (Slovakia)

^e Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

^f NATIONAL INSTITUTE OF CARDIOVASCULAR DISEASES   (Slovakia)

^g ETH ZURICH   (Switzerland)

^h INSTITUTE OF MEASUREMENT SCIENCE   (Slovakia)

ⁱ Center of Excellence   (Austria)

^j MEDICAL UNIVERSITY OF VIENNA   (Austria)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; FIBRONECTIN TYPE 3 DOMAIN CONTAINING PROTEIN 5; GLUCOSE; INSULIN; IRISIN; MEMBRANE PROTEIN; MESSENGER RNA; MUSCLE PROTEIN; PALMITIC ACID; UNCLASSIFIED DRUG;

ABDOMINAL WALL MUSCULATURE; ADIPOSE TISSUE; ADULT; AEROBIC CAPACITY; ARTICLE; BODY COMPOSITION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIET RESTRICTION; DOWN REGULATION; EXERCISE; FAT CONTENT; FEMALE; FNDC5 GENE; GENE; GLUCOSE TOLERANCE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERINSULINEMIA; IMPAIRED GLUCOSE TOLERANCE; IN VITRO STUDY; IN VIVO STUDY; INSULIN SENSITIVITY; LIVER PARENCHYMA; MAJOR CLINICAL STUDY; MALE; MUSCLE MASS; MUSCLE METABOLISM; MUSCLE STRENGTH; MUSCLE TISSUE; MYOTUBE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTON NUCLEAR MAGNETIC RESONANCE; SEDENTARY LIFESTYLE; SKELETAL MUSCLE; SUBCUTANEOUS TISSUE; TRAINING;

ADIPOSE TISSUE; ADULT; DIABETES MELLITUS, TYPE 2; EXERCISE THERAPY; FEMALE; FIBRONECTINS; HUMANS; MALE; MUSCLE, SKELETAL; OBESITY;

EID: 84896730221     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2013.264655     Document Type: Article

References (27)

1. Bordicchia M, Liu D, Amri EZ, Ailhaud G, Dessi-Fulgheri P, Zhang C, Takahashi N, Sarzani R & Collins S (2012). Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes. J Clin Invest 122, 1022-1036.
2. Boström P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, Rasbach KA, Boström EA, Choi JH, Long JZ, Kajimura S, Zingaretti MC, Vind BF, Tu H, Cinti S, Højlund K, Gygi SP & Spiegelman BM (2012). A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481, 463-468.
3. Bouzakri K, Plomgaard P, Berney T, Donath MY, Pedersen BK & Halban PA (2011). Bimodal effect on pancreatic β-cells of secretory products from normal or insulin-resistant human skeletal muscle. Diabetes 60, 1111-1121.
4. 31P NMR magnetization-transfer measurements of ATP turnover during steady-state isometric muscle contraction in the rat hind limb in vivo. Biochemistry 28, 4887-4893.
5. Choi YK, Kim MK, Bae KH, Seo HA, Jeong JY, Lee WK, Kim JG, Lee IK & Park KG (2013). Serum irisin levels in new-onset type 2 diabetes. Diabetes Res Clin Pract 100, 96-101.
6. Dun SL, Lyu RM, Chen YH, Chang JK, Luo JJ & Dun NJ (2013). Irisin-immunoreactivity in neural and non-neural cells of the rodent. Neuroscience 240, 155-162.
7. Geiselman PJ, Anderson AM, Dowdy ML, West DB, Redmann SM & Smith SR (1998). Reliability and validity of a macronutrient self-selection paradigm and a food preference questionnaire. Physiol Behav 63, 919-928.
8. Huh JY, Panagiotou G, Mougios V, Brinkoetter M, Vamvini MT, Schneider BE & Mantzoros CS (2012). FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism 61, 1725-1738.
9. Irving BA, Robinson MM & Nair KS (2012). Age effect on myocellular remodeling: response to exercise and nutrition in humans. Ageing Res Rev 11, 374-389.
10. Jiang LQ, Duque-Guimaraes DE, Machado UF, Zierath JR & Krook A (2013). Altered response of skeletal muscle to IL-6 in type 2 diabetic patients. Diabetes 62, 355-361.
11. Lebon V, Dufour S, Petersen KF, Ren J, Jucker BM, Slezak LA, Cline GW, Rothman DL & Shulman GI (2001). Effect of triiodothyronine on mitochondrial energy coupling in human skeletal muscle. J Clin Invest 108, 733-737.
12. Lecker SH, Zavin A, Cao P, Arena R, Allsup K, Daniels KM, Joseph J, Schulze PC & Forman DE (2012). Expression of the irisin precursor FNDC5 in skeletal muscle correlates with aerobic exercise performance in patients with heart failure. Circ Heart Fail 5, 812-818.
13. Liu J-J, Wong M, Toy W, Tan C, Liu S, Ng X, Tavintharan S, Sum C & Lim S (2013). Lower circulating irisin is associated with type 2 diabetes mellitus. J Diabetes Complications 27, 365-369.
14. Moreno-Navarrete JM, Ortega F, Serrano M, Guerra E, Pardo G, Tinahones F, Ricart W & Fernández-Real JM (2013). Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab 98, E769-E778.
15. Pedersen BK & Febbraio MA (2008). Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol Rev 88, 1379-1406.
16. Polyzos SA, Kountouras J, Shields K & Mantzoros CS (2013). Irisin: A renaissance in metabolism? Metabolism 62, 1037-1044.
17. Roca-Rivada A, Castelao C, Senin LL, Landrove MO, Baltar J, Belén Crujeiras A, Seoane LM, Casanueva FF & Pardo M (2013). FNDC5/irisin is not only a myokine but also an adipokine. Plos One 8, e60563.
18. Sparks LM, Moro C, Ukropcova B, Bajpeyi S, Civitarese AE, Hulver MW, Thoresen GH, Rustan AC & Smith SR (2011). Remodeling lipid metabolism and improving insulin responsiveness in human primary myotubes. PLoS One 6, e21068.
19. Spiegelman BM (2013). Banting Lecture 2012: Regulation of adipogenesis: toward new therapeutics for metabolic disease. Diabetes 62, 1774-1782.
20. Staiger H, Böhm A, Scheler M, Berti L, Machann J, Schick F, Machicao F, Fritsche A, Stefan N, Weigert C, Krook A, Häring HU & de Angelis MH (2013). Common genetic variation in the human FNDC5 locus, encoding the novel muscle-derived 'browning' factor irisin, determines insulin sensitivity. PLoS One 8, e61903.
21. Stengel A, Hofmann T, Goebel-Stengel M, Elbelt U, Kobelt P & Klapp BF (2013). Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity - Correlation with body mass index. Peptides 39, 125-130.
22. Swick AG, Orena S & O'Connor A (2013). Irisin levels correlate with energy expenditure in a subgroup of humans with energy expenditure greater than predicted by fat free mass. Metabolism 62, 1070-1073.
23. Teufel A, Malik N, Mukhopadhyay M & Westphal H (2002). Frcp1 and Frcp2, two novel fibronectin type III repeat containing genes. Gene 297, 79-83.
24. Timmons JA, Baar K, Davidsen PK & Atherton PJ (2012). Is irisin a human exercise gene? Nature 488, E9-E10.
25. Ukropcova B, McNeil M, Sereda O, de Jonge L, Xie H, Bray GA & Smith SR (2005). Dynamic changes in fat oxidation in human primary myocytes mirror metabolic characteristics of the donor. J Clin Invest 115, 1934-1941.
26. Ukropec J, Penesova A, Skopkova M, Pura M, Vlcek M, Radikova Z, Imrich R, Ukropcova B, Tajtakova M, Koska J, Zorad S, Belan V, Vanuga P, Payer J, Eckel J, Klimes I & Gasperikova D (2008). Adipokine protein expression pattern in growth hormone deficiency predisposes to the increased fat cell size and the whole body metabolic derangements. J Clin Endocrinol Metab 93, 2255-2262.
27. 31P-MRS metabolism measurements in resting and exercised quadriceps muscle of overweight-to-obese sedentary individuals. NMR Biomed 26, 1714-1722.